Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1068162-79-7

Post Buying Request

1068162-79-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1068162-79-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1068162-79-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,8,1,6 and 2 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1068162-79:
(9*1)+(8*0)+(7*6)+(6*8)+(5*1)+(4*6)+(3*2)+(2*7)+(1*9)=157
157 % 10 = 7
So 1068162-79-7 is a valid CAS Registry Number.

1068162-79-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-4-(3-chloro-4-cyanophenyl)benzonitrile

1.2 Other means of identification

Product number -
Other names 3,3'-Dichlor-biphenyl-4,4'-dicarbonitril

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1068162-79-7 SDS

1068162-79-7Downstream Products

1068162-79-7Relevant articles and documents

An Enantioselective Hydrogenation of an Alkenoic Acid as a Key Step in the Synthesis of AZD2716

Karlsson, Staffan,S?rensen, Henrik,Andersen, S?ren M.,Cruz, Angele,Ryberg, Per

, p. 262 - 269 (2016/03/04)

A classical resolution of a racemic carboxylic acid through salt formation and an asymmetric hydrogenation of an α,β-unsaturated carboxylic acid were investigated in parallel to prepare an enantiomerically pure alkanoic acid used as a key intermediate in the synthesis of an antiplaque candidate drug. After an extensive screening of rhodium- and ruthenium-based catalysts, we developed a rhodium-catalyzed hydrogenation that gave the alkanoic acid with 90% ee, and after a subsequent crystallization with (R)-1-phenylethanamine, the ee was enriched to 97%. The chiral acid was then used in sequential Negishi and Suzuki couplings followed by basic hydrolysis of a nitrile to an amide to give the active pharmaceutical ingredient in 22% overall yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1068162-79-7